Quick Answer
Opus Genetics, Inc. reported Total Assets of $50.24 million for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +36.3% in Total Assets from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $21.88 million | Q3 2011: $18.69 million | Q1 2012: $11.71 million | Q2 2012: $9.76 million | Q3 2012: $7.98 million | Q1 2013: $13.35 million | Q2 2013: $11.07 million | Q3 2013: $16.07 million | Q1 2014: $41.12 million | Q2 2014: $39.24 million | Q3 2014: $36.45 million | Q1 2015: $30.48 million | Q2 2015: $27.37 million | Q3 2015: $23.07 million | Q1 2016: $25.56 million | Q2 2016: $20.53 million | Q3 2016: $22.74 million | Q1 2017: $19.58 million | Q2 2017: $28.09 million | Q3 2017: $24.59 million | Q1 2018: $22.55 million | Q2 2018: $18.24 million | Q3 2018: $13.87 million | Q1 2019: $19.43 million | Q2 2019: $17.68 million | Q3 2019: $14.98 million | Q1 2020: $11.55 million | Q2 2020: $10.25 million | Q3 2020: $8.83 million | Q1 2021: $12.13 million | Q2 2021: $25.25 million | Q3 2021: $23.20 million | Q1 2022: $20.49 million | Q2 2022: $17.90 million | Q3 2022: $14.57 million | Q1 2023: $45.40 million | Q2 2023: $43.47 million | Q3 2023: $54.19 million | Q1 2024: $51.84 million | Q2 2024: $44.83 million | Q3 2024: $40.39 million | Q1 2025: $48.17 million | Q2 2025: $38.67 million | Q3 2025: $36.12 million.
- Over the full 16 years of available data (2010 to 2025), Opus Genetics, Inc.'s Total Assets has grown by 209.8%.
- Historical annual values: Fiscal year 2025: $50.24 million | Fiscal year 2024: $36.86 million | Fiscal year 2023: $53.95 million | Fiscal year 2022: $48.99 million | Fiscal year 2021: $26.08 million | Fiscal year 2020: $17.68 million | Fiscal year 2019: $1.78 million | Fiscal year 2018: $16.04 million | Fiscal year 2017: $28.29 million | Fiscal year 2016: $21.04 million | Fiscal year 2015: $24.81 million | Fiscal year 2014: $33.53 million | Fiscal year 2013: $19.56 million | Fiscal year 2012: $14.92 million | Fiscal year 2011: $13.69 million | Fiscal year 2010: $16.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: